最新論文發表

• 
  2022-01-14 最新論文發表

  Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B

  楊懷壹, 陳建仁
  AP&T Alimentary Pharmacology & Therapeutics

• 
  2021-12-14 最新論文發表

  Homogeneous antibody and CAR-T cell targeting glycan on pancreatic cancer

  翁啟惠
  PNAS

• 
  2021-11-24 最新論文發表

  Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection

  楊懷壹, 陳建仁
  JHEP Reports

• 
  2021-11-23 最新論文發表

  Novel monodisperse FePt nanocomposites for T2-weighted magnetic resonance imaging: biomedical theranostics applications

  蕭宏昇
  Nanoscale Advances

• 
  2021-10-15 最新論文發表

  Immunogenicity evaluation of N-glycans recognized by HIV broadly neutralizing antibodies

  翁啟惠
  ACS Chemical Biology

• 
  2021-10-09 最新論文發表

  Magnetically Guided Theranostics: Montmorillonite-Based Iron/Platinum Nanoparticles for Enhancing in Situ MRI Contrast and Hepatocellular Carcinoma Treatment

  蕭宏昇
  Journal of Nanobiotechnology

• 
  2021-08-20 最新論文發表

  Combined effect of anti-SSEA4 and anti-Globo H antibodies on breast cancer cells

  翁啟惠
  ACS Chemical Biology

• 
  2021-08-05 最新論文發表

  A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells

  林國儀
  PLoS Pathogens

• 
  2021-07-13 最新論文發表

  Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function

  黃雯華
  Scientific Reports

• 
  2021-07-01 最新論文發表

  SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection

  謝世良
  The Journal of Clinical Investigation